Fubotv earnings beat by $0.10, revenue topped estimates
TD Cowen has reiterated its Buy rating and $22.50 price target on Alphatec Holdings (NASDAQ:ATEC) on Monday, describing the recent share pullback as "unjustified" and highlighting a "compelling" setup for the second half of 2025. The company maintains a "GOOD" financial health score according to InvestingPro data, with impressive revenue growth of 25.5% over the last twelve months.
The medical technology company’s stock has declined 7.5% over the past week, though it has gained 23% over the past six months. TD Cowen characterized the recent pullback as "unwarranted" and creating "an intriguing buying opportunity for investors," with the stock currently trading below its InvestingPro Fair Value.
TD Cowen pointed to several catalysts expected in the latter half of 2025, including potential beat-and-raise financial performances and significant pipeline updates, particularly the launch of the Valence robot.
The research firm expressed confidence that Alphatec is positioned for "a strong second half of 2025 with healthy quarterly performances and key updates coming from its pipeline."
The recent share price decline represents "an attractive buying opportunity for investors" given the positive outlook for the company’s near-term performance, according to TD Cowen’s analysis.
In other recent news, Alphatec Holdings reported mixed financial results for the first quarter of 2025. The company’s earnings per share (EPS) came in at -$0.35, missing the analyst forecast of -$0.12, while revenue slightly exceeded expectations, reaching $169 million compared to the anticipated $167.98 million. Despite the earnings miss, revenue grew by 22% year-over-year, with surgical revenue showing a 24% increase. Lake Street Capital Markets assumed coverage of Alphatec with a buy rating, highlighting the company’s specialized focus in spine treatments as a key factor for expected growth. The firm set a price target of $18.00, reflecting confidence in Alphatec’s strategic direction. The company continues to expand its market presence internationally, particularly in regions like Australia, New Zealand, and Japan. Alphatec’s management remains optimistic about becoming cash flow positive by the end of the year, with a full-year revenue guidance of $734 million, representing a 20% growth. Additionally, the company is working on developing a robotic system with navigation capabilities, which is anticipated to launch by the end of the year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.